MIGERSI

MIGERSI was founded in 2021 as an innovative medical device company focusing on minimally invasive ophthalmology, originating from active cationic polymerization biomaterials technology. The company’s investment entity is based in Chongqing, while its operational entity is located in Chengdu Tianfu International Bio City, closely following the integration trend of Sichuan and Chongqing and leveraging the coordinated resources of both regions to accelerate corporate development. MIGERSI has established two key business development directions: a materials technology platform and the research and development of minimally invasive ophthalmic devices. The materials technology platform synthesizes the SIBS material system through active cationic polymerization technology. With the collaboration of Chengdu Tianfu International Bio City's biomaterials and innovation center, a stable and mass-production setup has been established, and the company is currently undergoing ISO13485 system certification.